Mingzhu Liu - Search Results

Year	Number of Results
2003	2
2005	3
2006	5
2007	4
2008	5
2009	6
2010	9
2011	9
2012	13
2013	12
2014	7
2015	4
2016	9
2017	21
2018	18
2019	26
2020	23
2021	25
2022	30
2023	41
2024	13

1

Protein post-translational modification in SARS-CoV-2 and host interaction.

Cheng N, Liu M, Li W, Sun B, Liu D, Wang G, Shi J, Li L. Cheng N, et al. Among authors: liu m. Front Immunol. 2023 Jan 13;13:1068449. doi: 10.3389/fimmu.2022.1068449. eCollection 2022. Front Immunol. 2023. PMID: 36713387 Free PMC article. Review.

2

Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation.

Liu X, Ye Y, Zhu L, Xiao X, Zhou B, Gu Y, Si H, Liang H, Liu M, Li J, Jiang Q, Li J, Yu S, Ma R, Su S, Liao JY, Zhao Q. Liu X, et al. Among authors: liu m. Nat Commun. 2023 Jan 16;14(1):238. doi: 10.1038/s41467-023-35856-y. Nat Commun. 2023. PMID: 36646707 Free PMC article.

3

Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer.

Niu N, Shen X, Wang Z, Chen Y, Weng Y, Yu F, Tang Y, Lu P, Liu M, Wang L, Sun Y, Yang M, Shen B, Jin J, Lu Z, Jiang K, Shi Y, Xue J. Niu N, et al. Among authors: liu m. Cancer Cell. 2024 Apr 4:S1535-6108(24)00090-4. doi: 10.1016/j.ccell.2024.03.005. Online ahead of print. Cancer Cell. 2024. PMID: 38579725

4

Shape-Shifting Patchy Particles.

Zheng X, Liu M, He M, Pine DJ, Weck M. Zheng X, et al. Among authors: liu m. Angew Chem Int Ed Engl. 2017 May 8;56(20):5507-5511. doi: 10.1002/anie.201701456. Epub 2017 Apr 12. Angew Chem Int Ed Engl. 2017. PMID: 28402010

5

Biomarkers for Prostate Cancer: From Diagnosis to Treatment.

Chen JY, Wang PY, Liu MZ, Lyu F, Ma MW, Ren XY, Gao XS. Chen JY, et al. Diagnostics (Basel). 2023 Oct 31;13(21):3350. doi: 10.3390/diagnostics13213350. Diagnostics (Basel). 2023. PMID: 37958246 Free PMC article. Review.

6

Tumor Cell-Intrinsic SETD2 Deficiency Reprograms Neutrophils to Foster Immune Escape in Pancreatic Tumorigenesis.

Niu N, Shen X, Zhang L, Chen Y, Lu P, Yang W, Liu M, Shi J, Xu D, Tang Y, Yang X, Weng Y, Zhao X, Wu LM, Sun Y, Xue J. Niu N, et al. Among authors: liu m. Adv Sci (Weinh). 2023 Jan;10(2):e2202937. doi: 10.1002/advs.202202937. Epub 2022 Dec 1. Adv Sci (Weinh). 2023. PMID: 36453584 Free PMC article.

7

Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease.

Long XQ, Liu MZ, Liu ZH, Xia LZ, Lu SP, Xu XP, Wu MH. Long XQ, et al. World J Gastroenterol. 2023 Jul 21;29(27):4252-4270. doi: 10.3748/wjg.v29.i27.4252. World J Gastroenterol. 2023. PMID: 37545642 Free PMC article. Review.

8

Customized Chiral Colloids.

Liu M, Dong F, Jackson NS, Ward MD, Weck M. Liu M, et al. J Am Chem Soc. 2020 Sep 30;142(39):16528-16532. doi: 10.1021/jacs.0c07315. Epub 2020 Sep 15. J Am Chem Soc. 2020. PMID: 32931280

9

Multi-hadron molecules: status and prospect.

Wu TW, Pan YW, Liu MZ, Geng LS. Wu TW, et al. Sci Bull (Beijing). 2022 Sep 15;67(17):1735-1738. doi: 10.1016/j.scib.2022.08.007. Epub 2022 Aug 6. Sci Bull (Beijing). 2022. PMID: 36546057 No abstract available.

10

A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia.

Wang P, Xiao X, Zhang Y, Zhang B, Li D, Liu M, Xie X, Liu C, Liu P, Ren R. Wang P, et al. Among authors: liu m. J Hematol Oncol. 2021 Jul 3;14(1):105. doi: 10.1186/s13045-021-01098-y. J Hematol Oncol. 2021. PMID: 34217323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

248 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Results by year